MRT Co., Ltd. (MRT) is a corporation located at 1-18-2 Jinnan, Shibuya-ku, Tokyo, established on January 26, 2000 and headed by Tomoya Ogawa, CEO (corporate number: 3011101059533). The last registration update was on December 25, 2015, and the location was changed.
Financial results for the fiscal year ending December 2022 (sales: 8,738 million yen, net income: 2,159 million yen) are posted. Employees and former employees have rated Career Change Conference at 2.7/5.0 points and Caixa's reputation at 78/100 points on various review sites.
There is no legal violation/disposition/black information posted.
Company Profile
| Corporate number | 3011101059533 |
|---|---|
| Corporate name | MRT Co., Ltd. |
| Furigana | MRT |
| Address/Map | 1-18-2 Jinnan, Shibuya-ku, Tokyo 150-0041 View on Google Maps |
| Stock code | 6034 TSE Growth |
| President/Representative | Representative Director Tomoya Ogawa Chairman of the Board Hyoe Tomita |
| URL | https://medrt.co.jp/ |
| telephone number | 03-6415-5280 |
| Establishment | January 26, 2000 |
| Industry | service industry |
| Business content | ≪Providing a medical information platform≫
|
| Corporate number designation date | 2015/10/05 |
| Last registration update date | 2015/12/25 |
Press release & advertisement from MRT Co., Ltd.
Financial history of MRT Co., Ltd. (million yen)
| year | quarter | Submission date | sales revenue | Operating profit | Ordinary profit | Net income | Comprehensive income for the period |
|---|---|---|---|---|---|---|---|
Individual for the fiscal year ended March 31, 2014 | Full-year results | 2015/05/12 | 728 | 56 | 69 | 6 | – |
Individual for the fiscal year ending March 2015 | 2Q results | 2015/10/27 | 453 | 146 | 144 | 91 | – |
| 3Q results | 2015/01/30 | 670 | 191 | 177 | 112 | – | |
| Full year revision | 2015/01/30 | 830 | 166 | 150 | 95 | – | |
| Full-year results | 2015/05/12 | 831 | 173 | 155 | 95 | – | |
March 2016 /piece | 1Q results | 2015/07/28 | 288 | 101 | 101 | 69 | – |
| 2Q results | 2015/10/27 | 520 | 150 | 150 | 100 | – | |
| 3Q results | 2016/01/26 | 776 | 219 | 211 | 147 | 147 | |
| Full year revision | 2016/01/26 | 1,000 | 180 | 165 | 108 | – | |
| Full year revision | 2016/05/09 | 1,001 | 199 | 184 | 140 | – | |
| Full-year results | 2016/05/10 | 1,001 | 199 | 184 | 140 | 139 | |
| ending March 2017 | 1Q results | 2016/07/26 | 293 | 89 | 84 | 54 | 52 |
| 2Q results | 2016/10/25 | 552 | 144 | 130 | 82 | 79 | |
| 3Q results | 2017/02/07 | 849 | 206 | 186 | 121 | 120 | |
| Full year forecast | 2016/05/10 | 1,200 | 213 | 190 | 116 | – | |
| Full year revision | 2017/03/31 | 1,140 | 135 | 105 | 10 | – | |
| Full-year results | 2017/05/09 | 1,159 | 155 | 126 | 32 | 31 | |
| ending March 2018 | 1Q results | 2017/08/10 | 395 | 82 | – | 46 | 33 |
| 2Q results | 2017/11/14 | 748 | 119 | – | 65 | 41 | |
| 3Q results | 2018/02/13 | 1,130 | 97 | – | 38 | 12 | |
| Full year forecast | 2017/05/09 | 1,500 | 141 | 128 | 80 | – | |
| Full year revision | 2017/08/10 | 1,520 | 30 | – | 10 | – | |
| Full-year results | 2018/05/15 | 1,501 | 64 | – | 31 | 11 | |
| ending March 2019 | 1Q results | 2018/08/14 | 709 | 170 | – | 83 | 99 |
| 2Q results | 2018/11/13 | 1,177 | 145 | – | 163 | 172 | |
| 3Q results | 2019/02/12 | 1,727 | 164 | – | 180 | 181 | |
| Full year forecast | 2018/05/15 | 2,100 | 40 | – | 20 | – | |
| Full year revision | 2019/02/12 | 40 | 40 | – | 85 | – | |
| Full-year results | 2019/05/14 | 2,232 | 52 | – | 97 | 71 | |
| ending December 2019 * 9 months | 1Q results | 2019/08/13 | 713 | 112 | – | 67 | 75 |
| 2Q results | 2019/11/12 | 1,319 | 172 | – | 101 | 112 | |
| Full year revision | 2019/06/21 | 120 | – | – | 70 | – | |
| Full year revision | 2019/08/13 | 1,900 | 120 | – | 70 | – | |
| Full-year results | 2020/02/14 | 1,973 | 198 | – | 108 | 101 | |
Consolidated for December 2020 | 1Q results | 2020/05/15 | 579 | 23 | – | 6 | -45 |
| 2Q results | 2020/08/11 | 1,293 | 156 | – | 81 | 41 | |
| 3Q results | 2020/11/10 | 1,928 | 222 | – | 110 | 50 | |
| Full year forecast | 2020/02/14 | 2,500 | 250 | – | 130 | – | |
| Full-year results | 2021/02/12 | 2,562 | 264 | – | 131 | 98 | |
| ending December 2021 | 1Q results | 2021/05/14 | 531 | -63 | – | -42 | -52 |
| 2Q results | 2021/08/13 | 1,645 | 341 | – | 206 | 232 | |
| 3Q results | 2021/11/12 | 3,258 | 1,099 | – | 710 | 743 | |
| Full year revision | 2021/11/12 | 4,000 | 1,150 | – | 750 | – | |
| Full-year results | 2022/02/14 | 4,469 | 1,280 | – | 753 | 717 | |
| ending December 2022 | 1Q results | 2022/05/13 | 2,334 | 863 | – | 574 | 576 |
| 2Q results | 2022/08/12 | 5,445 | 2,065 | – | 1,369 | 1,389 | |
| 3Q results | 2022/11/11 | 6,989 | 2,588 | – | 1,737 | 1,788 | |
| Full year revision | 2022/08/12 | 7,000 | 2,200 | – | 1,420 | – | |
| Full year revision | 2022/11/11 | 8,000 | 2,650 | – | 1,770 | – | |
| Full-year results | 2023/02/14 | 8,738 | 2,977 | – | 2,159 | 2,191 | |
| ending December 2023 | 1Q results | 2023/05/12 | 1,765 | 439 | – | 291 | 299 |
| 2Q results | 2023/08/10 | 3,239 | 803 | – | 526 | 551 | |
| 3Q results | 2023/11/14 | 4,348 | 941 | – | 602 | 640 | |
| year | quarter | Submission date | sales revenue | Operating profit | Ordinary profit | Net income | Comprehensive income for the period |
![Medicinal hair growth agent [hair tonic glow gel]](https://companydata.tsujigawa.com/wp-content/uploads/2024/07/hair-tonic-glow-gel-pr-01-150x150.jpg)
